Johnson & Johnson (JNJ) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Johnson & Johnson

NYSE | JNJ

190.80

USD

$0.00

(

0.00%

)

At Close (As of Oct 14, 2025)

$459.75B

Market Cap

20.44

P/E Ratio

9.34

EPS

$192.10

52 Week High

$137.37

52 Week Low

HEALTHCARE

Sector

JNJ Chart

Recent Chart

Price Action

JNJ Technicals

Tags:

JNJ Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$61B
Total Revenue	$89B
Cost Of Revenue	$27B
Costof Goods And Services Sold	$27B
Operating Income	$22B
Selling General And Administrative	$22B
Research And Development	$17B
Operating Expenses	$67B
Investment Income Net	-
Net Interest Income	$577M
Interest Income	$1.3B
Interest Expense	$755M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$7.3B
Income Before Tax	$17B
Income Tax Expense	$2.6B
Interest And Debt Expense	-
Net Income From Continuing Operations	$14B
Comprehensive Income Net Of Tax	-
Ebit	$17B
Ebitda	$25B
Net Income	$14B

Revenue & Profitability

Earnings Performance

JNJ Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2024)

Field	Value (USD)
Total Assets	$180B
Total Current Assets	$56B
Cash And Cash Equivalents At Carrying Value	$24B
Cash And Short Term Investments	$24B
Inventory	$12B
Current Net Receivables	$15B
Total Non Current Assets	$124B
Property Plant Equipment	-
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	$38B
Intangible Assets Excluding Goodwill	$38B
Goodwill	$44B
Investments	-
Long Term Investments	-
Short Term Investments	$417M
Other Current Assets	-
Other Non Current Assets	-
Total Liabilities	$109B
Total Current Liabilities	$50B
Current Accounts Payable	$10B
Deferred Revenue	-
Current Debt	-
Short Term Debt	$6B
Total Non Current Liabilities	$58B
Capital Lease Obligations	-
Long Term Debt	$31B
Current Long Term Debt	$6B
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$37B
Other Current Liabilities	$30B
Other Non Current Liabilities	$18B
Total Shareholder Equity	$71B
Treasury Stock	-
Retained Earnings	-
Common Stock	-
Common Stock Shares Outstanding	$2.4B

yearly Cash Flow (As of Dec 31, 2024)

Field	Value (USD)
Operating Cashflow	$24B
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$7.3B
Capital Expenditures	$4.4B
Change In Receivables	-
Change In Inventory	-$1.1B
Profit Loss	-
Cashflow From Investment	-$19B
Cashflow From Financing	-$3.1B
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	$12B
Dividend Payout Common Stock	$12B
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-$2.4B
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	$14B

yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$61B
Total Revenue	$89B
Cost Of Revenue	$27B
Costof Goods And Services Sold	$27B
Operating Income	$22B
Selling General And Administrative	$22B
Research And Development	$17B
Operating Expenses	$67B
Investment Income Net	-
Net Interest Income	$577M
Interest Income	$1.3B
Interest Expense	$755M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$7.3B
Income Before Tax	$17B
Income Tax Expense	$2.6B
Interest And Debt Expense	-
Net Income From Continuing Operations	$14B
Comprehensive Income Net Of Tax	-
Ebit	$17B
Ebitda	$25B
Net Income	$14B

Dividends

Field	Value
Ex Dividend Date	2025-08-26
Declaration Date	2025-07-16
Record Date	2025-08-26
Payment Date	2025-09-09
Amount	1.3

JNJ News

JNJ Profile

Johnson & Johnson Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - GENERAL

Johnson & Johnson (JNJ) is a leading American multinational corporation established in 1886, specializing in the development and manufacturing of healthcare products across three segments: medical devices, pharmaceuticals, and consumer health products. With a strong reputation for innovation and quality, J&J is a key player in the global healthcare market and is recognized as one of the world's most valuable companies. As a component of the Dow Jones Industrial Average, the company holds a premier AAA credit rating, reflecting its financial stability and strong operational performance. Ranked No. 36 on the Fortune 500 list, J&J continues to leverage its extensive portfolio to drive sustainable growth and enhance its position as a trusted provider of health solutions.

Symbol	Price	Change %	Market Cap	Volume
VHAI	$0.00	+66.66%	$2.64M	883,708,745
YYAI	$0.15	-9.70%	$2.77M	208,963,303
BURU	$0.41	-18.90%	$62.82M	197,521,038
CGBS	$0.03	-39.47%	$18.16M	197,485,133
BITF	$6.03	+11.87%	$2.32B	166,210,110

Symbol	Price	Change %	Market Cap	Volume
NVO	$56.69	-1.40%	$259.42B	4,683,711
PFE	$24.69	-0.14%	$140.89B	24,645,355
BMY	$43.46	-0.18%	$89.48B	7,975,403
CL	$76.98	-1.25%	$63.01B	5,757,958
HLN	$9.15	+0.78%	$40.59B	5,831,075

Symbol	Price	Change %	Market Cap	Volume
AQMS	$23.84	+140.56%	$11.02M	22,552,199
EDHL	$0.97	+95.69%	$20.00M	79,578,605
NVA	$66.38	+94.32%	$157.52M	6,799,411
GWAV	$16.08	+88.96%	$4.10M	22,482,338
ELAB	$9.10	+74.66%	$4.07M	19,064,600

Symbol	Price	Change %	Market Cap	Volume
SCPX	$0.00	-97.27%	$393.80K	21,515
ICCT	$0.00	-96.66%	$43.89K	3,168
GOTU	$2.98	-88.06%	$730.72M	335,439
SHOT	$0.39	-74.37%	$67.15M	13,958,900
CARM	$0.04	-70.30%	$6.43M	5,067,526

Quick Links

JNJ $0.00 (0.00% ) Quote details